A journal is planning to retract a paper that purported to link a component of vaccines to autism in mice. The paper, about the effects of aluminum adjuvants in vaccines on the immune response in the brains of mice, is the second retraction for co-authors Christopher Shaw and Lucija Tomljenovic, of the University of British … Continue reading Journal to retract paper called “anti-vaccine pseudoscience”
The week at Retraction Watch featured admissions of fake data from a biotech company whose compound is now in clinical trials, a look at who recycles text, and the apparent demotion of a researcher who had a paper on video games retracted. Here’s what was happening elsewhere:
A biologist who studied the impact of diabetes on the eye inappropriately altered data in five images from three papers, according to a new finding of misconduct issued by the U.S. Office of Research Integrity (ORI). Readers may be familiar with the subject of the findings: Azza El-Remessy, a former tenured associate professor at the … Continue reading ORI finds misconduct in case of biologist paid $100K by university to leave
A journal has removed an expression of concern for a 2011 paper after Karolinska Institutet (KI) “concluded no wrongdoing had occurred.” In June, Journal of Cell Science (JCS) issued the expression of concern, after a reader contacted the editors with questions about the data in one of the figures. JCS investigated but could not resolve … Continue reading “No wrongdoing had occurred,” says Karolinska, following investigation of cancer research
The Journal of Biological Chemistry has added an expression of concern to a 2003 paper that arose from the PhD thesis of a once-prominent — and controversial — science journalist in Australia. The first author of the paper is Maryanne Demasi, a journalist whose reporting created unintentional headlines in recent years. In 2013, she produced … Continue reading Controversial Australian journalist’s paper flagged by journal
Earlier this month, we reported the retraction of several papers published by researchers with appointments at both the University of California, San Francisco (UCSF) and the San Francisco Veterans Administration (VA) Medical Center, led by a prominent urologist. Recently, we obtained the letters sent to the journals that retracted the papers, shedding some additional light … Continue reading UCSF-VA letters to journals offer insight into misconduct investigations
The week at Retraction Watch featured a post on just how much an authorship costs if you want to buy one, anger over charges to use a common research tool, and the revocation of a PhD from a once-rising star scientist. Here’s what was happening elsewhere:
Earlier this year, the University of California, San Francisco and the San Francisco Veterans Administration Medical Center teamed up to write a letter. Addressed to the editorial office at the American Association of Cancer Research (AACR), the letter, parts of which have been published in a retraction notice, contained information concerning two papers on genetic … Continue reading UCSF, VA investigations find “clear evidence” of misconduct in cancer papers
Pfizer has discovered two additional papers that merit retraction from the lab of a former employee. One of the papers, published in Clinical Cancer Research, was retracted earlier this month. Last year, Pfizer requested retractions of five papers from the lab of breast cancer researcher Min-Jean Yin, who was fired after an investigation revealed image duplication. … Continue reading Case closed? Fired Pfizer researcher slated for seven retractions
In December of last year, Chris Surridge found himself in a situation not uncommon to journal editors: A researcher who had been found to have committed misconduct had submitted a manuscript to the journal Surridge edits, Nature Plants. Retraction Watch readers may recall the name of the corresponding author, Patrice Dunoyer, who has had five papers … Continue reading What should a journal do when a scientist who committed misconduct submits a new paper?